BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Savitz SI, Chopp M, Deans R, Carmichael T, Phinney D, Wechsler L; STEPS Participants. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011;42:825-9. [PMID: 21273569 DOI: 10.1161/STROKEAHA.110.601914] [Cited by in Crossref: 186] [Cited by in F6Publishing: 173] [Article Influence: 16.9] [Reference Citation Analysis]
Number Citing Articles
1 Kaiser EE, Waters ES, Yang X, Fagan MM, Scheulin KM, Sneed SE, Cheek SR, Jeon JH, Shin SK, Kinder HA, Kumar A, Platt SR, Duberstein KJ, Park HJ, Xie J, West FD. Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model. Stem Cells Transl Med 2022:szac062. [PMID: 36124817 DOI: 10.1093/stcltm/szac062] [Reference Citation Analysis]
2 Yang Y, Hu X, Qin Q, Kong F, Peng X, Zhao J, Si J, Yang Z, Xie S. Optimal therapeutic conditions for the neural stem cell-based management of ischemic stroke: a systematic review and network meta-analysis based on animal studies. BMC Neurol 2022;22:345. [PMID: 36096751 DOI: 10.1186/s12883-022-02875-z] [Reference Citation Analysis]
3 Takamiya S, Kawabori M, Kitahashi T, Nakamura K, Mizuno Y, Yasui H, Kuge Y, Tanimori A, Takamatsu Y, Yuyama K, Shichinohe H, Fujimura M, Cantore S. Intracerebral Transplantation of Mesenchymal Stromal Cell Compounded with Recombinant Peptide Scaffold against Chronic Intracerebral Hemorrhage Model. Stem Cells International 2022;2022:1-10. [DOI: 10.1155/2022/8521922] [Reference Citation Analysis]
4 Hacene S, Le Friec A, Desmoulin F, Robert L, Colitti N, Fitremann J, Loubinoux I, Cirillo C. Present and future avenues of cell-based therapy for brain injury: The enteric nervous system as a potential cell source. Brain Pathol 2022;:e13105. [PMID: 35773942 DOI: 10.1111/bpa.13105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lin X, Li N, Tang H. Recent Advances in Nanomaterials for Diagnosis, Treatments, and Neurorestoration in Ischemic Stroke. Front Cell Neurosci 2022;16:885190. [DOI: 10.3389/fncel.2022.885190] [Reference Citation Analysis]
6 Jin X, Li P, Michalski D, Li S, Zhang Y, Jolkkonen J, Cui L, Didwischus N, Xuan W, Boltze J. Perioperative stroke: A perspective on challenges and opportunities for experimental treatment and diagnostic strategies. CNS Neurosci Ther 2022;28:497-509. [PMID: 35224865 DOI: 10.1111/cns.13816] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Li H, Liu Y. The hopes and hypes of plant and bacteria-derived cellulose application in stem cell technology. Cellulose. [DOI: 10.1007/s10570-022-04443-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rahman MM, Islam MR, Islam MT, Harun-Or-Rashid M, Islam M, Abdullah S, Uddin MB, Das S, Rahaman MS, Ahmed M, Alhumaydhi FA, Emran TB, Mohamed AA, Faruque MRI, Khandaker MU, Mostafa-Hedeab G. Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives. Biology (Basel) 2022;11:147. [PMID: 35053145 DOI: 10.3390/biology11010147] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
9 Gu BJ, Kung DK, Chen HI. Cell Therapy for Stroke: A Mechanistic Analysis. Neurosurgery 2021;88:733-45. [PMID: 33370810 DOI: 10.1093/neuros/nyaa531] [Reference Citation Analysis]
10 Lourbopoulos A, Mourouzis I, Xinaris C, Zerva N, Filippakis K, Pavlopoulos A, Pantos C. Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal. Front Neurosci 2021;15:652403. [PMID: 34054413 DOI: 10.3389/fnins.2021.652403] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
11 Zhou G, Wang Y, Gao S, Fu X, Cao Y, Peng Y, Zhuang J, Hu J, Shao A, Wang L. Potential Mechanisms and Perspectives in Ischemic Stroke Treatment Using Stem Cell Therapies. Front Cell Dev Biol 2021;9:646927. [PMID: 33869200 DOI: 10.3389/fcell.2021.646927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ripley AJ, Jeffers MS, McDonald MW, Montroy J, Dykes A, Fergusson DA, Silasi G, Lalu MM, Corbett D. Neuroprotection by Remote Ischemic Conditioning in Rodent Models of Focal Ischemia: a Systematic Review and Meta-Analysis. Transl Stroke Res 2021;12:461-73. [PMID: 33405011 DOI: 10.1007/s12975-020-00882-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
13 Li WY, Zhu QB, Jin LY, Yang Y, Xu XY, Hu XY. Exosomes derived from human induced pluripotent stem cell-derived neural progenitor cells protect neuronal function under ischemic conditions. Neural Regen Res 2021;16:2064-70. [PMID: 33642395 DOI: 10.4103/1673-5374.308665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Golubczyk D, Kalkowski L, Kwiatkowska J, Zawadzki M, Holak P, Glodek J, Milewska K, Pomianowski A, Janowski M, Adamiak Z, Walczak P, Malysz-Cymborska I. Endovascular model of ischemic stroke in swine guided by real-time MRI. Sci Rep 2020;10:17318. [PMID: 33057149 DOI: 10.1038/s41598-020-74411-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kawabori M, Shichinohe H, Kuroda S, Houkin K. Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke. Int J Mol Sci 2020;21:E7380. [PMID: 33036265 DOI: 10.3390/ijms21197380] [Cited by in Crossref: 8] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
16 Park YJ, Niizuma K, Mokin M, Dezawa M, Borlongan CV. Cell-Based Therapy for Stroke: Musing With Muse Cells. Stroke 2020;51:2854-62. [PMID: 32811374 DOI: 10.1161/STROKEAHA.120.030618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
17 Xu F, Zhang Q, Wang H. Establishing a density-based method to separate proliferating and senescent cells from bone marrow stromal cells. Aging (Albany NY) 2020;12:15050-7. [PMID: 32710730 DOI: 10.18632/aging.103569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Li Z, Dong X, Tian M, Liu C, Wang K, Li L, Liu Z, Liu J. Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials. Stem Cell Res Ther 2020;11:252. [PMID: 32586371 DOI: 10.1186/s13287-020-01762-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
19 Abe T, Aburakawa D, Niizuma K, Iwabuchi N, Kajitani T, Wakao S, Kushida Y, Dezawa M, Borlongan CV, Tominaga T. Intravenously Transplanted Human Multilineage-Differentiating Stress-Enduring Cells Afford Brain Repair in a Mouse Lacunar Stroke Model. Stroke 2020;51:601-11. [DOI: 10.1161/strokeaha.119.026589] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
20 Diekhorst L, Gómez-de Frutos MC, Laso-García F, Otero-Ortega L, Fuentes B, Jolkkonen J, Detante O, Moisan A, Leyva L, Martínez-Arroyo A, Díez-Tejedor E, Gutiérrez-Fernández M; RESSTORE Consortium. Mesenchymal Stem Cells From Adipose Tissue Do not Improve Functional Recovery After Ischemic Stroke in Hypertensive Rats. Stroke 2020;51:342-6. [PMID: 31694504 DOI: 10.1161/STROKEAHA.119.027133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Boltze J, Modo MM, Mays RW, Taguchi A, Jolkkonen J, Savitz SI; STEPS 4 Consortium. Stem Cells as an Emerging Paradigm in Stroke 4: Advancing and Accelerating Preclinical Research. Stroke. 2019;50:3299-3306. [PMID: 31658004 DOI: 10.1161/strokeaha.119.025436] [Cited by in Crossref: 31] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
22 Balkaya M, Cho S. Optimizing functional outcome endpoints for stroke recovery studies. J Cereb Blood Flow Metab 2019;39:2323-42. [PMID: 31522590 DOI: 10.1177/0271678X19875212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
23 Tuazon JP, Castelli V, Borlongan CV. Drug-like delivery methods of stem cells as biologics for stroke. Expert Opin Drug Deliv 2019;16:823-33. [PMID: 31311344 DOI: 10.1080/17425247.2019.1645116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Gómez-de Frutos MC, Laso-García F, Diekhorst L, Otero-Ortega L, Fuentes B, Jolkkonen J, Detante O, Moisan A, Martínez-Arroyo A, Díez-Tejedor E, Gutiérrez-Fernández M; RESSTORE consortium. Intravenous delivery of adipose tissue-derived mesenchymal stem cells improves brain repair in hyperglycemic stroke rats. Stem Cell Res Ther 2019;10:212. [PMID: 31315686 DOI: 10.1186/s13287-019-1322-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
25 Mangin G, Cogo A, Moisan A, Bonnin P, Maïer B, Kubis N; RESSTORE Consortium. Intravenous Administration of Human Adipose Derived-Mesenchymal Stem Cells Is Not Efficient in Diabetic or Hypertensive Mice Subjected to Focal Cerebral Ischemia. Front Neurosci 2019;13:718. [PMID: 31379478 DOI: 10.3389/fnins.2019.00718] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
26 Krause M, Phan TG, Ma H, Sobey CG, Lim R. Cell-Based Therapies for Stroke: Are We There Yet? Front Neurol 2019;10:656. [PMID: 31293500 DOI: 10.3389/fneur.2019.00656] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
27 Dief AE, Hassan PS, Hartmut O, Jirikowski GF. Neuronal and glial regeneration after focal cerebral ischemia in rat, an immunohistochemical and electron microscopical study. Alexandria Journal of Medicine 2018;54:699-704. [DOI: 10.1016/j.ajme.2018.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
28 Dabrowski A, Robinson TJ, Felling RJ. Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies. Curr Neurol Neurosci Rep 2019;19:5. [PMID: 30712068 DOI: 10.1007/s11910-019-0920-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
29 Liao LY, Lau BW, Sánchez-Vidaña DI, Gao Q. Exogenous neural stem cell transplantation for cerebral ischemia. Neural Regen Res 2019;14:1129-37. [PMID: 30804235 DOI: 10.4103/1673-5374.251188] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
30 Myneni VD, McClain-Caldwell I, Martin D, Vitale-Cross L, Marko K, Firriolo JM, Labow BI, Mezey E. Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cells. Cytotherapy 2019;21:148-61. [PMID: 30595353 DOI: 10.1016/j.jcyt.2018.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zheng H, Zhang B, Chhatbar PY, Dong Y, Alawieh A, Lowe F, Hu X, Feng W. Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research. Cell Transplant 2018;27:1723-30. [PMID: 30343609 DOI: 10.1177/0963689718806846] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
32 Nahhas MI, Hess DC. Stem Cell Therapy in Cerebrovascular Disease. Curr Treat Options Neurol 2018;20:49. [PMID: 30298218 DOI: 10.1007/s11940-018-0532-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Langhof H, Chin WWL, Wieschowski S, Federico C, Kimmelman J, Strech D. Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study. Br J Pharmacol 2018;175:4229-38. [PMID: 30153701 DOI: 10.1111/bph.14485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
34 Leavitt RJ, Limoli CL, Baulch JE. miRNA-based therapeutic potential of stem cell-derived extracellular vesicles: a safe cell-free treatment to ameliorate radiation-induced brain injury. Int J Radiat Biol. 2019;95:427-435. [PMID: 30252569 DOI: 10.1080/09553002.2018.1522012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
35 Yoon JS, Jo D, Lee HS, Yoo SW, Lee TY, Hwang WS, Choi JM, Kim E, Kim SS, Suh-Kim H. Spatiotemporal Protein Atlas of Cell Death-Related Molecules in the Rat MCAO Stroke Model. Exp Neurobiol 2018;27:287-98. [PMID: 30181691 DOI: 10.5607/en.2018.27.4.287] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
36 Suzuki N, Arimitsu N, Shimizu J, Takai K, Hirotsu C, Ueda Y, Wakisaka S, Fujiwara N, Suzuki T. Neuronal Cell Sheets of Cortical Motor Neuron Phenotype Derived from Human iPSCs. Cell Transplant 2017;26:1355-64. [PMID: 28901192 DOI: 10.1177/0963689717720280] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Tan C, Zhao S, Higashikawa K, Wang Z, Kawabori M, Abumiya T, Nakayama N, Kazumata K, Ukon N, Yasui H, Tamaki N, Kuge Y, Shichinohe H, Houkin K. [18F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia. EJNMMI Res 2018;8:35. [PMID: 29717383 DOI: 10.1186/s13550-018-0392-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
38 Ahn SM, Kim YR, Shin YI, Ha KT, Lee SY, Shin HK, Choi BT. Therapeutic Potential of a Combination of Electroacupuncture and TrkB-Expressing Mesenchymal Stem Cells for Ischemic Stroke. Mol Neurobiol 2019;56:157-73. [PMID: 29682700 DOI: 10.1007/s12035-018-1067-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
39 Lau VW, Platt SR, Grace HE, Baker EW, West FD. Human iNPC therapy leads to improvement in functional neurologic outcomes in a pig ischemic stroke model. Brain Behav 2018;8:e00972. [PMID: 29761021 DOI: 10.1002/brb3.972] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
40 Webb RL, Kaiser EE, Jurgielewicz BJ, Spellicy S, Scoville SL, Thompson TA, Swetenburg RL, Hess DC, West FD, Stice SL. Human Neural Stem Cell Extracellular Vesicles Improve Recovery in a Porcine Model of Ischemic Stroke. Stroke. 2018;49:1248-1256. [PMID: 29650593 DOI: 10.1161/strokeaha.117.020353] [Cited by in Crossref: 96] [Cited by in F6Publishing: 112] [Article Influence: 24.0] [Reference Citation Analysis]
41 Houkin K, Shichinohe H, Abe K, Arato T, Dezawa M, Honmou O, Horie N, Katayama Y, Kudo K, Kuroda S, Matsuyama T, Miyai I, Nagata I, Niizuma K, Sakushima K, Sasaki M, Sato N, Sawanobori K, Suda S, Taguchi A, Tominaga T, Yamamoto H, Yamashita T, Yoshimine T; Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction. Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products. Stroke 2018;49:e145-52. [PMID: 29581346 DOI: 10.1161/STROKEAHA.117.019216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
42 Ishrat T, Fouda AY, Pillai B, Eldahshan W, Ahmed H, Waller JL, Ergul A, Fagan SC. Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 2019;39:1635-47. [PMID: 29537907 DOI: 10.1177/0271678X18764773] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
43 Orczykowski ME, Arndt KR, Palitz LE, Kramer BC, Pessina MA, Oblak AL, Finklestein SP, Mortazavi F, Rosene DL, Moore TL. Cell based therapy enhances activation of ventral premotor cortex to improve recovery following primary motor cortex injury. Exp Neurol 2018;305:13-25. [PMID: 29540323 DOI: 10.1016/j.expneurol.2018.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
44 Kim YR, Ahn SM, Pak ME, Lee HJ, Jung DH, Shin YI, Shin HK, Choi BT. Potential benefits of mesenchymal stem cells and electroacupuncture on the trophic factors associated with neurogenesis in mice with ischemic stroke. Sci Rep 2018;8:2044. [PMID: 29391466 DOI: 10.1038/s41598-018-20481-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
45 Evans MA, Lim R, Kim HA, Chu HX, Gardiner-Mann CV, Taylor KWE, Chan CT, Brait VH, Lee S, Dinh QN, Vinh A, Phan TG, Srikanth VK, Ma H, Arumugam TV, Fann DY, Poh L, Hunt CPJ, Pouton CW, Haynes JM, Selemidis S, Kwan W, Teo L, Bourne JA, Neumann S, Young S, Gowing EK, Drummond GR, Clarkson AN, Wallace EM, Sobey CG, Broughton BRS. Acute or Delayed Systemic Administration of Human Amnion Epithelial Cells Improves Outcomes in Experimental Stroke. Stroke 2018;49:700-9. [PMID: 29382802 DOI: 10.1161/STROKEAHA.117.019136] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
46 Webb RL, Kaiser EE, Scoville SL, Thompson TA, Fatima S, Pandya C, Sriram K, Swetenburg RL, Vaibhav K, Arbab AS, Baban B, Dhandapani KM, Hess DC, Hoda MN, Stice SL. Human Neural Stem Cell Extracellular Vesicles Improve Tissue and Functional Recovery in the Murine Thromboembolic Stroke Model. Transl Stroke Res. 2018;9:530-539. [PMID: 29285679 DOI: 10.1007/s12975-017-0599-2] [Cited by in Crossref: 84] [Cited by in F6Publishing: 117] [Article Influence: 16.8] [Reference Citation Analysis]
47 Detante O, Muir K, Jolkkonen J. Cell Therapy in Stroke-Cautious Steps Towards a Clinical Treatment. Transl Stroke Res 2018;9:321-32. [PMID: 29150739 DOI: 10.1007/s12975-017-0587-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
48 Napoli E, Borlongan CV. Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered. Stem Cell Rev Rep 2017;13:192-7. [PMID: 28064388 DOI: 10.1007/s12015-016-9716-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
49 Baker EW, Platt SR, Lau VW, Grace HE, Holmes SP, Wang L, Duberstein KJ, Howerth EW, Kinder HA, Stice SL, Hess DC, Mao H, West FD. Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model. Sci Rep 2017;7:10075. [PMID: 28855627 DOI: 10.1038/s41598-017-10406-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 9.6] [Reference Citation Analysis]
50 Nagpal A, Choy FC, Howell S, Hillier S, Chan F, Hamilton-Bruce MA, Koblar SA. Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis. Stem Cell Res Ther. 2017;8:191. [PMID: 28854961 DOI: 10.1186/s13287-017-0643-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
51 Grankvist H, Kimmelman J. How do researchers decide early clinical trials? Med Health Care Philos 2016;19:191-8. [PMID: 26833467 DOI: 10.1007/s11019-016-9685-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
52 Wei L, Wei ZZ, Jiang MQ, Mohamad O, Yu SP. Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke. Prog Neurobiol. 2017;157:49-78. [PMID: 28322920 DOI: 10.1016/j.pneurobio.2017.03.003] [Cited by in Crossref: 67] [Cited by in F6Publishing: 82] [Article Influence: 13.4] [Reference Citation Analysis]
53 Liska MG, Crowley MG, Borlongan CV. Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke. Transl Stroke Res 2017;8:93-103. [PMID: 28127687 DOI: 10.1007/s12975-017-0522-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
54 Chen J, Ning R, Zacharek A, Cui C, Cui X, Yan T, Venkat P, Zhang Y, Chopp M. MiR-126 Contributes to Human Umbilical Cord Blood Cell-Induced Neurorestorative Effects After Stroke in Type-2 Diabetic Mice. Stem Cells 2016;34:102-13. [PMID: 26299579 DOI: 10.1002/stem.2193] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
55 Duss SB, Seiler A, Schmidt MH, Pace M, Adamantidis A, Müri RM, Bassetti CL. The role of sleep in recovery following ischemic stroke: A review of human and animal data. Neurobiol Sleep Circadian Rhythms 2017;2:94-105. [PMID: 31236498 DOI: 10.1016/j.nbscr.2016.11.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
56 Lundberg J, Jussing E, Liu Z, Meng Q, Rao M, Samén E, Grankvist R, Damberg P, Dodoo E, Maeurer M, Holmin S. Safety of Intra-Arterial Injection With Tumor-Activated T Cells to the Rabbit Brain Evaluated by MRI and SPECT/CT. Cell Transplant 2017;26:283-92. [PMID: 27725029 DOI: 10.3727/096368916X693347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
57 Rosado-de-Castro PH, de Carvalho FG, de Freitas GR, Mendez-Otero R, Pimentel-Coelho PM. Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral Hemorrhage. Stem Cells Int 2016;2016:4617983. [PMID: 27698671 DOI: 10.1155/2016/4617983] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
58 Napoli E, Borlongan CV. Recent Advances in Stem Cell-Based Therapeutics for Stroke. Transl Stroke Res 2016;7:452-7. [PMID: 27515852 DOI: 10.1007/s12975-016-0490-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
59 Rodríguez-Frutos B, Otero-Ortega L, Gutiérrez-Fernández M, Fuentes B, Ramos-Cejudo J, Díez-Tejedor E. Stem Cell Therapy and Administration Routes After Stroke. Transl Stroke Res 2016;7:378-87. [PMID: 27384771 DOI: 10.1007/s12975-016-0482-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
60 Martínez-garza D, Cantú-rodríguez O, Jaime-pérez J, Gutiérrez-aguirre C, Góngora-rivera J, Gómez-almaguer D. Current state and perspectives of stem cell therapy for stroke. Medicina Universitaria 2016;18:169-80. [DOI: 10.1016/j.rmu.2016.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
61 Shichinohe H, Houkin K. Cell Therapy for Stroke: Review of Previous Clinical Trials and Introduction of Our New Trials. Neurol Med Chir (Tokyo) 2016;56:592-6. [PMID: 27302193 DOI: 10.2176/nmc.st.2016-0087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
62 Carmichael ST. Emergent properties of neural repair: elemental biology to therapeutic concepts. Ann Neurol 2016;79:895-906. [PMID: 27043816 DOI: 10.1002/ana.24653] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
63 Jolkkonen J, Kwakkel G. Translational Hurdles in Stroke Recovery Studies. Transl Stroke Res 2016;7:331-42. [PMID: 27000881 DOI: 10.1007/s12975-016-0461-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]
64 Kuroda S. Current Opinion of Bone Marrow Stromal Cell Transplantation for Ischemic Stroke. Neurol Med Chir (Tokyo) 2016;56:293-301. [PMID: 26984453 DOI: 10.2176/nmc.ra.2015-0349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
65 Cui LL, Kinnunen T, Boltze J, Nystedt J, Jolkkonen J. Clumping and Viability of Bone Marrow Derived Mesenchymal Stromal Cells under Different Preparation Procedures: A Flow Cytometry-Based In Vitro Study. Stem Cells Int 2016;2016:1764938. [PMID: 27022399 DOI: 10.1155/2016/1764938] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
66 Nam HS, Kwon I, Lee BH, Kim H, Kim J, An S, Lee OH, Lee PH, Kim HO, Namgoong H, Kim YD, Heo JH. Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery. PLoS One 2015;10:e0144218. [PMID: 26637168 DOI: 10.1371/journal.pone.0144218] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
67 Bang OY. Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic Stroke. J Clin Neurol 2016;12:14-20. [PMID: 26610894 DOI: 10.3988/jcn.2016.12.1.14] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
68 Suda S, Yang B, Schaar K, Xi X, Pido J, Parsha K, Aronowski J, Savitz SI. Autologous Bone Marrow Mononuclear Cells Exert Broad Effects on Short- and Long-Term Biological and Functional Outcomes in Rodents with Intracerebral Hemorrhage. Stem Cells Dev 2015;24:2756-66. [PMID: 26414707 DOI: 10.1089/scd.2015.0107] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
69 Yin Y, Zhou X, Guan X, Liu Y, Jiang CB, Liu J. In vivo tracking of human adipose-derived stem cells labeled with ferumoxytol in rats with middle cerebral artery occlusion by magnetic resonance imaging. Neural Regen Res 2015;10:909-15. [PMID: 26199607 DOI: 10.4103/1673-5374.158355] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
70 Boltze J, Arnold A, Walczak P, Jolkkonen J, Cui L, Wagner DC. The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke. Front Neurol. 2015;6:155. [PMID: 26257702 DOI: 10.3389/fneur.2015.00155] [Cited by in Crossref: 77] [Cited by in F6Publishing: 85] [Article Influence: 11.0] [Reference Citation Analysis]
71 Qin J, Ma X, Qi H, Song B, Wang Y, Wen X, Wang QM, Sun S, Li Y, Zhang R, Liu X, Hou H, Gong G, Xu Y. Transplantation of Induced Pluripotent Stem Cells Alleviates Cerebral Inflammation and Neural Damage in Hemorrhagic Stroke. PLoS One. 2015;10:e0129881. [PMID: 26086994 DOI: 10.1371/journal.pone.0129881] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
72 Mering S, Jolkkonen J. Proper housing conditions in experimental stroke studies-special emphasis on environmental enrichment. Front Neurosci 2015;9:106. [PMID: 25870536 DOI: 10.3389/fnins.2015.00106] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
73 Choi DH, Kim JH, Lee KH, Kim HY, Kim YS, Choi WS, Lee J. Role of neuronal NADPH oxidase 1 in the peri-infarct regions after stroke. PLoS One 2015;10:e0116814. [PMID: 25617620 DOI: 10.1371/journal.pone.0116814] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
74 Horie N, Hiu T, Nagata I. Stem cell transplantation enhances endogenous brain repair after experimental stroke. Neurol Med Chir (Tokyo) 2015;55:107-12. [PMID: 25746304 DOI: 10.2176/nmc.ra.2014-0271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
75 Diamandis T, Borlongan CV. One, two, three steps toward cell therapy for stroke. Stroke 2015;46:588-91. [PMID: 25503552 DOI: 10.1161/STROKEAHA.114.007105] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
76 Ikegame Y, Yamashita K, Nakashima S, Nomura Y, Yonezawa S, Asano Y, Shinoda J, Hara H, Iwama T. Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke? Front Cell Neurosci 2014;8:322. [PMID: 25374506 DOI: 10.3389/fncel.2014.00322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
77 Ambrosio F, Boninger ML, Brubaker CE, Delitto A, Wagner WR, Shields RK, Wolf SL, Rando TA. Guest editorial: emergent themes from second annual symposium on regenerative rehabilitation, Pittsburgh, Pennsylvania. J Rehabil Res Dev 2013;50:vii-xiv. [PMID: 23881770 DOI: 10.1682/jrrd.2013.04.0081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
78 Platt SR, Holmes SP, Howerth EW, Duberstein KJJ, Dove CR, Kinder HA, Wyatt EL, Linville AV, Lau VW, Stice SL, Hill WD, Hess DC, West FD. Development and characterization of a Yucatan miniature biomedical pig permanent middle cerebral artery occlusion stroke model. Exp Transl Stroke Med 2014;6:5. [PMID: 24655785 DOI: 10.1186/2040-7378-6-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
79 Kalladka D, Muir KW. Brain repair: cell therapy in stroke. Stem Cells Cloning. 2014;7:31-44. [PMID: 24627643 DOI: 10.2147/sccaa.s38003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 47] [Article Influence: 2.5] [Reference Citation Analysis]
80 Canazza A, Minati L, Boffano C, Parati E, Binks S. Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cell-based therapies. Front Neurol 2014;5:19. [PMID: 24600434 DOI: 10.3389/fneur.2014.00019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
81 Minnerup J, Wagner DC, Strecker JK, Pösel C, Sevimli-Abdis S, Schmidt A, Schilling M, Boltze J, Diederich K, Schäbitz WR. Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats. Front Cell Neurosci 2014;7:288. [PMID: 24409120 DOI: 10.3389/fncel.2013.00288] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
82 Wang LQ, Lin ZZ, Zhang HX, Shao B, Xiao L, Jiang HG, Zhuge QC, Xie LK, Wang B, Su DM, Jin KL. Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke. CNS Neurosci Ther. 2014;20:317-326. [PMID: 24393245 DOI: 10.1111/cns.12216] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
83 Wali B, Ishrat T, Won S, Stein DG, Sayeed I. Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study. Brain 2014;137:486-502. [PMID: 24374329 DOI: 10.1093/brain/awt319] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
84 Savitz SI, Cramer SC, Wechsler L; STEPS 3 Consortium. Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke 2014;45:634-9. [PMID: 24368562 DOI: 10.1161/STROKEAHA.113.003379] [Cited by in Crossref: 112] [Cited by in F6Publishing: 96] [Article Influence: 12.4] [Reference Citation Analysis]
85 Liu X, Ye R, Yan T, Yu SP, Wei L, Xu G, Fan X, Jiang Y, Stetler RA, Liu G, Chen J. Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol. 2014;115:92-115. [PMID: 24333397 DOI: 10.1016/j.pneurobio.2013.11.007] [Cited by in Crossref: 133] [Cited by in F6Publishing: 121] [Article Influence: 14.8] [Reference Citation Analysis]
86 Chao F, Shen Y, Zhang H, Tian M. Multimodality molecular imaging of stem cells therapy for stroke. Biomed Res Int 2013;2013:849819. [PMID: 24222920 DOI: 10.1155/2013/849819] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
87 Kim SJ, Moon GJ, Chang WH, Kim YH, Bang OY; STARTING-2 (STem cell Application Researches and Trials In NeuroloGy-2) collaborators. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial. Trials 2013;14:317. [PMID: 24083670 DOI: 10.1186/1745-6215-14-317] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
88 Saito H, Magota K, Zhao S, Kubo N, Kuge Y, Shichinohe H, Houkin K, Tamaki N, Kuroda S. 123 I-Iomazenil Single Photon Emission Computed Tomography Visualizes Recovery of Neuronal Integrity by Bone Marrow Stromal Cell Therapy in Rat Infarct Brain. Stroke 2013;44:2869-74. [DOI: 10.1161/strokeaha.113.001612] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
89 Wang L, Ji H, Li M, Zhou J, Bai W, Zhong Z, Li N, Zhu D, Zhang Z, Liu Y, Wu M. Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety Study. ISRN Neurol 2013;2013:128591. [PMID: 24187628 DOI: 10.1155/2013/128591] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
90 Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med 2013;10:e1001489. [PMID: 23935460 DOI: 10.1371/journal.pmed.1001489] [Cited by in Crossref: 180] [Cited by in F6Publishing: 164] [Article Influence: 20.0] [Reference Citation Analysis]
91 Savitz SI. Cell therapies: careful translation from animals to patients. Stroke 2013;44:S107-9. [PMID: 23709699 DOI: 10.1161/STROKEAHA.112.679605] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
92 Eckert MA, Vu Q, Xie K, Yu J, Liao W, Cramer SC, Zhao W. Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J Cereb Blood Flow Metab. 2013;33:1322-1334. [PMID: 23756689 DOI: 10.1038/jcbfm.2013.91] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 10.1] [Reference Citation Analysis]
93 Shinozuka K, Staples M, Borlongan CV. Melatonin-based therapeutics for neuroprotection in stroke. Int J Mol Sci 2013;14:8924-47. [PMID: 23698756 DOI: 10.3390/ijms14058924] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
94 Gutiérrez-Fernández M, Fuentes B, Rodríguez-Frutos B, Ramos-Cejudo J, Vallejo-Cremades MT, Díez-Tejedor E. Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke. J Cell Mol Med 2012;16:2280-90. [PMID: 22452968 DOI: 10.1111/j.1582-4934.2012.01575.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
95 Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, Teresa Vallejo-Cremades M, Fuentes B, Cerdán S, Díez-Tejedor E. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther 2013;4:11. [PMID: 23356495 DOI: 10.1186/scrt159] [Cited by in Crossref: 161] [Cited by in F6Publishing: 153] [Article Influence: 17.9] [Reference Citation Analysis]
96 Dibajnia P, Morshead CM. Role of neural precursor cells in promoting repair following stroke. Acta Pharmacol Sin 2013;34:78-90. [PMID: 23064725 DOI: 10.1038/aps.2012.107] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
97 Misra V, Ritchie MM, Stone LL, Low WC, Janardhan V. Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology 2012;79:S207-12. [PMID: 23008400 DOI: 10.1212/WNL.0b013e31826959d2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
98 Zhao YH, Yuan B, Chen J, Feng DH, Zhao B, Qin C, Chen YF. Endothelial progenitor cells: therapeutic perspective for ischemic stroke. CNS Neurosci Ther 2013;19:67-75. [PMID: 23230897 DOI: 10.1111/cns.12040] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
99 Arifin DR, Kedziorek DA, Fu Y, Chan KW, McMahon MT, Weiss CR, Kraitchman DL, Bulte JW. Microencapsulated cell tracking. NMR Biomed 2013;26:850-9. [PMID: 23225358 DOI: 10.1002/nbm.2894] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
100 Lapchak PA, Zhang JH, Noble-Haeusslein LJ. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res 2013;4:279-85. [PMID: 23658596 DOI: 10.1007/s12975-012-0209-2] [Cited by in Crossref: 165] [Cited by in F6Publishing: 159] [Article Influence: 16.5] [Reference Citation Analysis]
101 Wang G. Hormesis, cell death, and regenerative medicine for neurode-generative diseases. Dose Response 2013;11:238-54. [PMID: 23930104 DOI: 10.2203/dose-response.12-019.Wang] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
102 Borlongan CV. Recent preclinical evidence advancing cell therapy for Alzheimer’s disease. Exp Neurol. 2012;237:142-146. [PMID: 22766481 DOI: 10.1016/j.expneurol.2012.06.024] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
103 Sakata H, Niizuma K, Wakai T, Narasimhan P, Maier CM, Chan PH. Neural stem cells genetically modified to overexpress cu/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. Stroke 2012;43:2423-9. [PMID: 22713489 DOI: 10.1161/STROKEAHA.112.656900] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
104 Machado A, Baker KB. Upside down crossed cerebellar diaschisis: proposing chronic stimulation of the dentatothalamocortical pathway for post-stroke motor recovery. Front Integr Neurosci 2012;6:20. [PMID: 22661933 DOI: 10.3389/fnint.2012.00020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
105 Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 2012;11:369-80. [PMID: 22441198 DOI: 10.1016/S1474-4422(12)70039-X] [Cited by in Crossref: 213] [Cited by in F6Publishing: 215] [Article Influence: 21.3] [Reference Citation Analysis]
106 Leong WK, Henshall TL, Arthur A, Kremer KL, Lewis MD, Helps SC, Field J, Hamilton-Bruce MA, Warming S, Manavis J. Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl Med. 2012;1:177-187. [PMID: 23197777 DOI: 10.5966/sctm.2011-0039] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 10.2] [Reference Citation Analysis]
107 Abe K, Yamashita T, Takizawa S, Kuroda S, Kinouchi H, Kawahara N. Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab 2012;32:1317-31. [PMID: 22252239 DOI: 10.1038/jcbfm.2011.187] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 9.4] [Reference Citation Analysis]
108 Lapchak PA. Scientific Rigor Recommendations for Optimizing the Clinical Applicability of Translational Research. J Neurol Neurophysiol 2012;3:e111. [PMID: 24490120 DOI: 10.4172/2155-9562.1000e111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
109 Jensen MB, Krishnaney-Davison R, Cohen LK, Zhang SC. Injected Versus Oral Cyclosporine for Human Neural Progenitor Grafting in Rats. J Stem Cell Res Ther 2012;Suppl 10:003. [PMID: 24765542 DOI: 10.4172/2157-7633.S10-003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
110 Cramer SC. Improving outcomes after stroke by LEAPS (Locomotor Experience Applied Post-Stroke) and bounds. Stroke 2011;42:3659-60. [PMID: 21980201 DOI: 10.1161/STROKEAHA.111.627992] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
111 Boltze J, Nitzsche B, Geiger KD, Schoon HA. Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model. Transl Stroke Res 2011;2:279-93. [PMID: 23440305 DOI: 10.1007/s12975-011-0101-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
112 Kokaia Z, Darsalia V. Neural stem cell-based therapy for ischemic stroke. Transl Stroke Res 2011;2:272-8. [PMID: 24323649 DOI: 10.1007/s12975-011-0100-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
113 Lindvall O, Kokaia Z. Stem cell research in stroke: how far from the clinic? Stroke 2011;42:2369-75. [PMID: 21757669 DOI: 10.1161/STROKEAHA.110.599654] [Cited by in Crossref: 132] [Cited by in F6Publishing: 111] [Article Influence: 12.0] [Reference Citation Analysis]
114 Lipsanen A, Jolkkonen J. Experimental approaches to study functional recovery following cerebral ischemia. Cell Mol Life Sci 2011;68:3007-17. [PMID: 21626271 DOI: 10.1007/s00018-011-0733-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]